Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Negri

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Medicina Nei Secoli|May 29, 2007
[Vittorio Erspamer (1909-1999)]Lucia Negri
Current Pharmaceutical Biotechnology|April 7, 2011
Bv8-prokineticins and their receptors: modulators of painLucia Negri, Roberta Lattanzi
Current Opinion in Pharmacology|December 6, 2011
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive systemLucia Negri, Roberta Lattanzi
Current Medicinal Chemistry|July 15, 2017
Targeting the Prokineticin System to Control Chronic Pain and InflammationLucia Negri, Daniela Maftei
Physiological Reviews|March 15, 2018
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent AngiogenesisLucia Negri, Napoleone Ferrara
Life Sciences|September 21, 2007
Bv8/Prokineticin proteins and their receptorsLucia Negri, Roberta Lattanzi, Elisa Giannini, et al.
Current Neuropharmacology|July 11, 2008
Modulators of pain: Bv8 and prokineticinsLucia Negri, Roberta Lattanzi, Elisa Giannini, et al.
Neuropeptides|September 27, 2018
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptorRoberta Lattanzi, Daniela Maftei, Lucia Negri, et al.
Frontiers in Pharmacology|September 21, 2018
<i>In vitro</i> and <i>in vivo</i> Pharmacological Activities of 14-<i>O</i>-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in MiceRoberta Lattanzi, Silvia Rief, Helmut Schmidhammer, et al.
Life Sciences|April 23, 2004
Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activationAntonella D'Ambrosio, Lia Noviello, Lucia Negri, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Medicina Nei Secoli|May 29, 2007
[Vittorio Erspamer (1909-1999)]Lucia Negri
Current Pharmaceutical Biotechnology|April 7, 2011
Bv8-prokineticins and their receptors: modulators of painLucia Negri, Roberta Lattanzi
Current Opinion in Pharmacology|December 6, 2011
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive systemLucia Negri, Roberta Lattanzi
Current Medicinal Chemistry|July 15, 2017
Targeting the Prokineticin System to Control Chronic Pain and InflammationLucia Negri, Daniela Maftei
Physiological Reviews|March 15, 2018
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent AngiogenesisLucia Negri, Napoleone Ferrara
Life Sciences|September 21, 2007
Bv8/Prokineticin proteins and their receptorsLucia Negri, Roberta Lattanzi, Elisa Giannini, et al.
Current Neuropharmacology|July 11, 2008
Modulators of pain: Bv8 and prokineticinsLucia Negri, Roberta Lattanzi, Elisa Giannini, et al.
Neuropeptides|September 27, 2018
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptorRoberta Lattanzi, Daniela Maftei, Lucia Negri, et al.
Frontiers in Pharmacology|September 21, 2018
<i>In vitro</i> and <i>in vivo</i> Pharmacological Activities of 14-<i>O</i>-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in MiceRoberta Lattanzi, Silvia Rief, Helmut Schmidhammer, et al.
Life Sciences|April 23, 2004
Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activationAntonella D'Ambrosio, Lia Noviello, Lucia Negri, et al.
Pageof 5